Varicella Zoster Vasculopathy Exacerbated by Tofacitinib in a Patient With Ulcerative Colitis

HomeStrokeVol. 54, No. 6Varicella Zoster Vasculopathy Exacerbated by Tofacitinib in a Patient With Ulcerative Colitis No AccessCase ReportRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessCase ReportRequest AccessFull TextVaricella Zoster Vasculopathy Exacerbated by Tofacitinib in a Patient With Ulcerative Colitis Kyle A. Lyman, Anirudh Sreekrishnan, Prateek Thatikunta, Ryan McConnell, Maarten G. Lansberg and Christina M. Mijalski Sells Kyle A. LymanKyle A. Lyman https://orcid.org/0000-0002-3309-7211 Department of Neurology and Neurological Sciences, Stanford University School of Medicine, CA (K.A.L., A.S., P.T., M.G.L., C.M.M.S.). Search for more papers by this author , Anirudh SreekrishnanAnirudh Sreekrishnan https://orcid.org/0000-0001-7251-7189 Department of Neurology and Neurological Sciences, Stanford University School of Medicine, CA (K.A.L., A.S., P.T., M.G.L., C.M.M.S.). Search for more papers by this author , Prateek ThatikuntaPrateek Thatikunta https://orcid.org/0000-0001-6542-2827 Department of Neurology and Neurological Sciences, Stanford University School of Medicine, CA (K.A.L., A.S., P.T., M.G.L., C.M.M.S.). Search for more papers by this author , Ryan McConnellRyan McConnell Department of Gastroenterology, Palo Alto Medical Foundation, CA (R.M.). Search for more papers by this author , Maarten G. LansbergMaarten G. Lansberg https://orcid.org/0000-0002-3545-6927 Department of Neurology and Neurological Sciences, Stanford University School of Medicine, CA (K.A.L., A.S., P.T., M.G.L., C.M.M.S.). Search for more papers by this author and Christina M. Mijalski SellsChristina M. Mijalski Sells Correspondence to: Christina M. Mijalski Sells, MD, MPH, Department of Neurology and Neurological Sciences, Center for Academic Medicine, 453 Quarry Rd, Stanford, CA 94305. Email E-mail Address: [email protected] Department of Neurology and Neurological Sciences, Stanford University School of Medicine, CA (K.A.L., A.S., P.T., M.G.L., C.M.M.S.). Search for more papers by this author Originally published6 Apr 2023https://doi.org/10.1161/STROKEAHA.122.042228Stroke. 2023;54:e246–e250FootnotesFor Sources of Funding and Disclosures, see page e250.Correspondence to: Christina M. Mijalski Sells, MD, MPH, Department of Neurology and Neurological Sciences, Center for Academic Medicine, 453 Quarry Rd, Stanford, CA 94305. Email [email protected]eduReferences1. Cheng-Ching E, Jones S, Hui FK, Man S, Gilden D, Bhimraj A, Uchino K. High-resolution MRI vessel wall imaging in varicella zoster virus vasculopathy.J Neurol Sci. 2015; 351:168–173. doi: 10.1016/j.jns.2015.02.017CrossrefMedlineGoogle Scholar2. Nagel MA, Gilden D. Update on varicella zoster zirus vasculopathy.Curr Infect Dis Rep. 2014; 16:407. doi: 10.1007/s11908-014-0407-zCrossrefMedlineGoogle Scholar3. Nagel MA, Niemeyer CS, Bubak AN. Central nervous system infections produced by varicella zoster virus.Curr Opin Infect Dis. 2020; 33:273–278. doi: 10.1097/QCO.0000000000000647CrossrefGoogle Scholar4. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment.Lancet Neurol. 2009; 8:731–740. doi: 10.1016/s1474-4422(09)70134-6CrossrefMedlineGoogle Scholar5. Nagel MA, Bubak AN. Varicella zoster virus vasculopathy.J Infect Dis. 2018; 218:S107–S112. doi: 10.1093/infdis/jiy425CrossrefGoogle Scholar6. Nagel MA, Cohrs RJ, Mahalingam R, Wellish MC, Forghani B, Schiller A, Safdieh JE, Kamenkovich E, Ostrow LW, Levy M, et al. The varicella zoster virus vasculopathies.Neurology. 2008; 70:853–860. doi: 10.1212/01.wnl.0000304747.38502.e8CrossrefMedlineGoogle Scholar7. Anand P. Neurologic infections in patients on immunomodulatory and immunosuppressive therapies.Continuum (Minneap Minn). 2021; 27:1066–1104. doi: 10.1212/CON.0000000000000985CrossrefGoogle Scholar8. Winthrop KL, Curtis JR, Yamaoka K, Lee EB, Hirose T, Rivas JL, Kwok K, Burmester GR. Clinical management of herpes zoster in patients with rheumatoid arthritis or psoriatic arthritis receiving tofacitinib treatment.Rheumatology Ther. 2022; 9:243–263. doi: 10.1007/s40744-021-00390-0CrossrefGoogle Scholar9. Klaric JS, Beltran TA, McClenathan BM. An association between herpes zoster vaccination and stroke reduction among elderly individuals.Mil Med. 2019; 184:126–132. doi: 10.1093/milmed/usy343CrossrefGoogle Scholar10. Silver B, Nagel MA, Mahalingam R, Cohrs R, Schmid DS, Gilden D. Varicella zoster virus vasculopathy: a treatable form of rapidly progressive multi-infarct dementia after 2 years’ duration.J Neurol Sci. 2012; 323:245–247. doi: 10.1016/j.jns.2012.07.059CrossrefGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetails June 2023Vol 54, Issue 6 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/STROKEAHA.122.042228PMID: 37021571 Originally publishedApril 6, 2023 Keywordsagedseizuresprednisoneherpes zosterbrainhumansPDF download Advertisement SubjectsCerebrovascular Disease/StrokeIschemic StrokeMagnetic Resonance Imaging (MRI)